Literature DB >> 27443043

Retinopathy of Prematurity: A Review of Current Screening Guidelines and Treatment Options.

Emily C Broxterman, Denise A Hug.   

Abstract

With advancements in neonatal intensive care units, the early detection of retinopathy of prematurity in premature infants is extremely important. It is critical for physicians to recognize children at risk and ensure they receive appropriate screening and monitoring. This article will discuss risk factors, screening guidelines, classification and treatment of this disease in premature infants.

Entities:  

Mesh：

Year:  2016        PMID： 27443043      PMCID： PMC6140066     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  9 in total

Review 1.  The International Classification of Retinopathy of Prematurity revisited.

Authors: 
Journal:  Arch Ophthalmol       Date:  2005-07

Review 2.  Screening examination of premature infants for retinopathy of prematurity.

Authors:  Walter M Fierson
Journal:  Pediatrics       Date:  2012-12-31       Impact factor: 7.124

3.  Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1988-04

4.  15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity.

Authors:  Earl A Palmer; Robert J Hardy; Velma Dobson; Dale L Phelps; Graham E Quinn; C Gail Summers; Carol P Krom; Betty Tung
Journal:  Arch Ophthalmol       Date:  2005-03

5.  A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome.

Authors:  Eugene Y J Ng; Brian P Connolly; J Arch McNamara; Carl D Regillo; James F Vander; William Tasman
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

6.  Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-08

7.  Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

Authors:  Helen A Mintz-Hittner; Kathleen A Kennedy; Alice Z Chuang
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

8.  Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial.

Authors:  William V Good
Journal:  Trans Am Ophthalmol Soc       Date:  2004

9.  Diode laser photocoagulation for threshold retinopathy of prematurity. A randomized study.

Authors:  D G Hunter; M X Repka
Journal:  Ophthalmology       Date:  1993-02       Impact factor: 12.079
  9 in total
  4 in total

1.  Refractive and biometrical characteristics of children with retinopathy of prematurity who received laser photocoagulation or intravitreal ranibizumab injection.

Authors:  Xiaofeng Lu; Xianlu Zeng; Miaohong Chen; Zixin Fan; Lei Zheng; Ya Tian; Shaochong Zhang; Ji C He; Guoming Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-05-12       Impact factor: 3.535

Review 2.  Vascular and Neuronal Protection in the Developing Retina: Potential Therapeutic Targets for Retinopathy of Prematurity.

Authors:  Jessica K W Tsang; Jin Liu; Amy C Y Lo
Journal:  Int J Mol Sci       Date:  2019-09-03       Impact factor: 5.923

3.  Using ROPScore and CHOP ROP for early prediction of retinopathy of prematurity in a Chinese population.

Authors:  Huiqing Sun; Yubin Dong; Yanxia Liu; Qingqin Chen; Yanxi Wang; Bin Cheng; Shaobo Qin; Liping Meng; Shanxiu Li; Yanlun Zhang; Aiguo Zhang; Weiling Yan; Yuhong Dong; Shuyi Cheng; Mingchao Li; Zengyuan Yu
Journal:  Ital J Pediatr       Date:  2021-02-18       Impact factor: 2.638

4.  Frequency of retinopathy of prematurity (ROP) in infants screened for ROP: two years follow-up results of a single center in Turkey.

Authors:  Adem Ugurlu
Journal:  Biomedicine (Taipei)       Date:  2021-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.